Oral Presentation ANZBA Annual Scientific Meeting 2025

Investigating the cytocompatibility of novel antimicrobial selenium nanoparticles for the treatment of burn wound infection (23021)

Alexandra Boyling 1 2 , Bravien Arrudsivah 1 2 , Tao Huang 3 , Xin Li 3 , Zhe Li 1 2 4 , Joanneke Maitz 1 2 4 , Justine O'Hara 4 5 , Peter Maitz 1 2 4 , Brooke Farrugia 3 , Daniel E Heath 3 , Neil O'Brien-Simpson 6 , Andrea J O'Connor 7
  1. Burns and Reconstructive Surgery Research Group, ANZAC Research Institute, Sydney, NSW, Australia
  2. Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
  3. Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Parkville, VIC, Australia
  4. Burns and Reconstructive Surgery Unit, Concord Repatriation General Hospital, Sydney, NSW, Australia
  5. Department of Plastic Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia
  6. ACTV Research Group, Melbourne Dental School and The Bio21 Institute of Molecular Science and Biotechnology, The University of Melbourne, Parkville, VIC, Australia
  7. Aikenhead Centre for Medical Discovery (ACMD), St Vincent’s Hospital Melbourne , Fitzroy, VIC, Australia
Publish consent withheld
  1. Huang, T., Holden, J.A., Reynolds, E.C., Heath, D.E., O’Brien-Simpson, N.M. and O’Connor, A.J., 2020. Multifunctional antimicrobial polypeptide-selenium nanoparticles combat drug-resistant bacteria. ACS applied materials & interfaces, 12(50), pp.55696-55709
  2. ISO. 10993-5: Biological evaluation of medical devices. Tests for in vitro cytotoxicity 2009.